In the new National-led coalition government, Act Party Leader and Epsom MP Hon David Seymour also holds an Associate Minister of Health portfolio. His specific responsibilities are Pharmac and Medsafe and, after reading CHPNZ’s Briefing to the Incoming Minister, invited CE Scott Milne and Chair Abs Saadi to his Parliamentary Office at the Beehive to meet with him and officials to hear the advice and concerns of CHPNZ’s membership.
Thank you to all that joined us for the CHPNZ AGM last Tuesday, 28 November. Our member turnout and engagement exceeded previous years and it was a wonderful opportunity to catch up with you all after what has been another busy year.
We’re very pleased to welcome Sashi Anantham, Head of IQVIA Consumer Insights and Intelligence ANZ, to speak to us after our AGM this year. Read below for more details on our AGM on November 28.
More than 40 CHPNZ members, in person and online, joined a large Medsafe team for a highly productive, positive and informative day in Wellington. Although we face some enormous challenges ahead, all participants were upbeat and keen to meet them head on, and through working collaboratively together.
The Therapeutics Products Bill will have an affect on all New Zealanders in some form. Whether you purchase medicines over the counter, import medicines, or if you have a business that sells natural health products.
The Therapeutics Products Bill will have an affect on all New Zealanders in some form. Whether you purchase medicines over the counter, import medicines, or if you have a business that sells natural health products.
The Consumer Healthcare Products Association of New Zealand (CHPNZ) has welcomed the government’s Winter Preparedness Plan and its initiatives designed to improve access, efficiency and primary health care but also cautions that work is needed on the regulation and supply of medicines so they can be accessed by the thousands of New Zealanders who will most benefit from the Plan.
Staff remain almost twice as long in pharmaceutical companies that offer internal mobility than those that do not, Australia’s ‘Pharma in Focus’ reports.
Staff remain almost twice as long in pharmaceutical companies that offer internal mobility than those that do not, Australia’s ‘Pharma in Focus’ reports.
With waiting times and costs to see a GP increasing, specialist GP Cathy Stephenson suggests pharmacies might be able to fill some of the healthcare gaps for rangatahi.